نتائج البحث

Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents.

• Authors : Abu-Awwad, Simona-Alina^1,2 (AUTHOR) ; Abu-Awwad, Ahmed^3,4 (AUTHOR) ; Suba, Madalina-Ianca^5,6 (AUTHOR)

• Source: Infectious Disease Reports. Jun2024, Vol. 16 Issue 3, p423-434. 12p.

تفاصيل العنوان

Resistance Trends of Antiretroviral Agents in People with Human Immunodeficiency Virus in Korea, 2012 - 2020.

• Authors : Sang-Min Oh^1,2; Jihwan Bang²; Sang-Won Park²

• Source: Infection & Chemotherapy. Sep2023, Vol. 55 Issue 3, p328-336. 9p.

تفاصيل العنوان

Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention.

• Authors : Yeon-Sook Kim¹

• Source: Infection & Chemotherapy. Dec2021, Vol. 53 Issue 4, p686-695. 10p.

تفاصيل العنوان

Overview of Forced Degradation Analysis for FDA Approved Antiretroviral agents: A Review.

• Authors : Lamichhane, Suman¹; Das, Bhaswati²; Adhikari, Rudra Prasad¹

• Source: Journal of Young Pharmacists. Jul-Sep2022, Vol. 14 Issue 3, p273-282. 10p.

تفاصيل العنوان

Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With Other Antiretroviral Agents in People Living With HIV (CALIBRATE)

• Source: Gupta SK, Berhe M, Crofoot G, et al. Long-Acting Subcutaneous Lenacapavir Dosed Every 6 Months as part of a Combination Regimen in Treatment-Naïve People with HIV: Interim 16-week Results of a

تفاصيل العنوان

The antiretroviral agents azidothymidine, stavudine, and didanosine have the identical mutational fingerprint in the rpoB region of Escherichia coli.

• Authors : Yaramada, Lekha¹ (AUTHOR); Singh, Sunjum¹ (AUTHOR); Ge, Zoe¹ (AUTHOR)

Subjects: *AZIDOTHYMIDINE; *REVERSE transcriptase inhibitors; *ESCHERICHIA coli

• Source: Environmental & Molecular Mutagenesis. Aug2022, Vol. 63 Issue 7, p329-335. 7p.

تفاصيل العنوان

Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents

• Authors : Simona-Alina Abu-Awwad; Ahmed Abu-Awwad; Madalina-Ianca Suba

Subjects: HIV; antiretroviral therapy; liver metabolic health

• Source: Infectious Disease Reports, Vol 16, Iss 3, Pp 423-434 (2024)

تفاصيل العنوان

Hepatitis B Virus Reactivation after Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody.

• Authors : Eisuke Adachi¹ ; Ayako Sedohara¹; Kotaro Arizono¹

Subjects: *HEPATITIS B virus; *HEPATITIS B; *VIRUS reactivationJAPAN

• Source: Emerging Infectious Diseases. Aug2024, Vol. 30 Issue 8, p1668-1671. 4p.

تفاصيل العنوان

Use of multiple pharmacies by people living with HIV.

• Authors : Sahloff, Eric G.¹ (AUTHOR) ; Sturgill, Kuan² (AUTHOR); Vaidya, Varun¹ (AUTHOR)

• Source: Discover Public Health. 7/31/2024, Vol. 21 Issue 1, p1-10. 10p.

تفاصيل العنوان

Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks.

• Authors : Mulindwa, Frank^1,2 (AUTHOR) ; Schwarz, Jean-Marc^3,4 (AUTHOR); Brusselaers, Nele^2,5 (AUTHOR)

• Source: BMC Infectious Diseases. 7/29/2024, Vol. 24 Issue 1, p1-10. 10p.

تفاصيل العنوان